We use cookies. Find out more about it here. By continuing to browse this site you are agreeing to our use of cookies.
#alert
Back to search results
New

Sr. Director, U.S. Asset Lead - Oncology (Lung & GU Tumors)

GlaxoSmithKline
United States, Pennsylvania, Philadelphia
2929 Walnut Street (Show on map)
Mar 24, 2026
Site Name: USA - Pennsylvania - Philadelphia
Posted Date: Mar 24 2026

Sr. Director, U.S. Asset Lead - Oncology (Lung & GU Tumors)

Location: Philadelphia, PA

The Sr. Director, U.S. Asset Lead is the primary U.S. commercial representative for the asset across lung and genitourinary (GU) tumors. This leader embeds U.S. market perspective into clinical development, regulatory and access strategy, and launch planning to maximize commercial value from development through lifecycle management. The role partners with global and U.S. functions to ensure development decisions support U.S. commercialization.

Key responsibilities:

U.S. as strategy & leadership

  • Act as U.S. commercial lead ensuring U.S. priorities are reflected in global asset decisions.
  • Define U.S. Target Product Profile, positioning, differentiation and value proposition versus competitors.
  • Translate U.S. market insights into actionable guidance for global teams.

Clinical development & indication strategy

  • Provide commercial input on indication prioritization, endpoints, comparator strategy, and trial design.
  • Identify label-optimizing opportunities and evidence needs to support U.S. access and adoption.

Market intelligence & competitive strategy

  • Support U.S. market landscape analyses: epidemiology, treatment pathways, competitive pipelines and emerging modalities.
  • Partner with Business Insights/Analytics to surface signals that drive strategic shifts.

Forecasting & business case

  • Collaborate on U.S. revenue forecasting, scenario planning and pricing/market uptake assumptions.
  • Inform investment, launch sequencing and lifecycle decisions with commercial assessments.

Launch readiness & commercialization

  • Inform U.S. launch planning: customer segmentation, messaging, access/pricing strategy and go-to-market model.
  • Support in the cross functional commercialization planning: Sales, Marketing, Market Access and Medical Affairs for coordinated launch execution.

Cross-functional & external engagement

  • Integrate with Global Asset Team, Medical, Regulatory, Market Access, and Forecasting.
  • Engage KOLs, advocacy groups and present at major oncology congresses to inform strategy and market shaping.

Leadership competencies

  • Strategic thinker with strong commercial acumen
  • Data-driven decision maker
  • Ability to influence without formal authority and drive cross-functional alignment
  • Balances near-term development priorities with long-term asset value
  • Impact
  • This role ensures the product is developed and positioned to achieve maximum clinical adoption and commercial success in the U.S. market by embedding U.S. evidence, access and commercialization needs into global development and launch decisions.

Why You?

Basic Qualifications

  • Bachelor's degree in business, life sciences, healthcare or related field; advanced degree preferred.
  • 10+ years in biopharma with substantial oncology commercial experience.
  • Demonstrated experience supporting late-stage clinical development, launch planning, and/or commercialization of oncology assets
  • Experience collaborating with crossfunctional stakeholders across Commercial, Medical, Regulatory, Market Access, and Forecasting in matrixed environments
  • Proven success influencing global, matrixed teams.

Preferred Qualifications

  • Advanced degree (MBA, PhD, PharmD, MD, or equivalent)
  • Direct commercial experience in lung cancer and/or genitourinary (GU) tumor indications
  • Experience serving as an asset lead or primary commercial representative on a global asset team
  • Hands-on involvement in U.S. launch execution, including positioning, pricing, access strategy, and gotomarket planning
  • Deep familiarity with U.S. payer evidence requirements, value frameworks, and access strategy for oncology therapies

#LI-GSK

Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases - to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we're committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

If you require an accommodation or other assistance to apply for a job at GSK, please contact the appropriate Recruitment Staff by emailing us at - usrecruitment.adjustments@gsk.com

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK's compliance to all federal and state US Transparency requirements. For more information, please visit the Centers for Medicare and Medicaid Services (CMS) website at https://openpaymentsdata.cms.gov/

Applied = 0

(web-bd9584865-vpmzc)